A detailed history of Saturna Capital Corp transactions in Zoetis Inc. stock. As of the latest transaction made, Saturna Capital Corp holds 6,475 shares of ZTS stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,475
Previous 6,475 -0.0%
Holding current value
$1.24 Million
Previous $1.1 Million 2.47%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $40,092 - $48,385
-242 Reduced 3.6%
6,475 $1.1 Million
Q4 2023

Feb 06, 2024

BUY
$151.44 - $200.09 $42,857 - $56,625
283 Added 4.4%
6,717 $1.33 Million
Q3 2023

Nov 14, 2023

SELL
$167.14 - $192.77 $14,039 - $16,192
-84 Reduced 1.29%
6,434 $1.12 Million
Q2 2023

Aug 04, 2023

BUY
$160.94 - $186.23 $13,518 - $15,643
84 Added 1.31%
6,518 $1.12 Million
Q1 2023

May 15, 2023

BUY
$145.48 - $175.02 $936,018 - $1.13 Million
6,434 New
6,434 $1.07 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $89.4B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.